ophthalmologytimes19h
FDA issues CRL to Astellas' Supplemental New Drug Application for avacincaptad pegol intravitreal solution (IZERVAY)
Astellas said in a press release that the FDA comments in the CRL relate to proposed labeling language, not safety.
NBC Los Angeles1d
FDA weighs in on diet drug shortage, creating more confusion about compounding
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
San Francisco Examiner1d
SF sets record for fewest monthly overdose deaths
San Francisco recorded fewer fatal overdoses in October than any other month since The City started tracking drug deaths in 2020, according to the Office of the Chief Medical Examiner’s preliminary ...
UBS: West Pharmaceutical Services, Inc. (NYSE:WST) Is A Bottom-Ranked Quant Stock
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, ...
federalnewsnetwork.com5d
FDA sees high vacancy rates for drug manufacturer inspectors
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
TMCnet5d
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug Products with Therapeutic Equivalence ... as well as costs related to excess or obsolete inventory. The increase in ...